Tyrosine-533 of rat dopamine transporter: Involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine

Molecular Brain Research

Volumn 56, Issue 1-2, 1998, Pages 84-88

  Mitsuhata, Chieko ^a   Kitayama, Shigeo ^a   Morita, Katsuya ^a   Vandenbergh, David ^b   Uhl, George R ^b,c   Dohi, Toshihiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Molecular Neurobiology   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cocaine; Dopamine transporter; MPP+; Mutagenesis

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALANINE; COCAINE; DOPAMINE TRANSPORTER; NEUROTRANSMITTER; PHENYLALANINE; TYROSINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN COS1; DRUG POTENCY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; COCAINE; COS CELLS; CRICETINAE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; RATS; SUBSTRATE SPECIFICITY; TYROSINE;

ANIMALIA;

EID: 0032078412     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00032-1     Document Type: Article

References (12)

1. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
2. Kitayama S., Dohi T. Cellular and molecular aspects of monoamine neurotransmitter transporters. Jpn. J. Pharmacol. 72:1996;195-208.
3. Kitayama S., Shimada S., Xu H., Markham L., Donovan D.M., Uhl G.R. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7782-7785.
4. + transport. Synapse. 15:1993;58-62.
5. + uptake and cocaine binding in bovine dopamine transporter. Neurosci. Lett. 214:1996;199-201.
6. 3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane. Mol. Pharmacol. 36:1989;518-524.
7. 3H]GBR-12935 binding to dopamine uptake sites in the human brain. Brain Res. 457:1988;122-129.
8. Pifl C., Giros B., Caron M.G. Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J. Neurosci. 13:1993;4246-4253.
9. Pifl C., Hornykiewicz O., Giros B., Caron M.G. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter. J. Pharmacol. Exp. Ther. 277:1996;1437-1443.
10. 3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinson's disease. Arch. Pharmacol. 329:1985;227-235.
11. Tipton K.F., Singer T.P. Advances in our understanding of mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61:1993;1191-1206.
12. Willoughby J., Cowburn R.F., Hardy J.A., Glover V., Sandler M. 1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes. J. Neurochem. 52:1989;627-631.